Prostate cancer is one of the leading causes of cancer-related death in men, and some experts project the number of cases to ...

Add Yahoo as a preferred source to see more of our stories on Google. A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, researchers ...

Long-term results from a European study showed that prostate cancer mortality was 13% lower in the PSA screening group versus the control group. Compared with the trial update at 16 years, the number ...

State data from 2018 through 2022 shows prostate cancer is the leading cancer diagnosis in Cuyahoga County, yet 77% of cases ...

SAN DIEGO (KGTV) — In honor of Black History Month, a prostate cancer survivor and local health leader is drawing attention to alarming disparities in prostate cancer diagnoses and deaths among Black ...

Cancer death rates in the UK have hit a record low, but the picture is more complicated than the headline figure suggests.

(NYSE: PFE) today announced positive topline results from the Phase 3 TALAPRO-3 study of TALZENNA ® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI ® ...

Starting next year, Louisiana could require health insurance plans to cover prostate cancer screenings starting at age 40, ...

People who have received a cancer diagnosis are living longer than ever, according to a new report from the American Cancer Society (ACS). Decades of cancer research have led to more effective ...

Early-stage prostate cancer rarely causes symptoms, making routine screening the most reliable way to catch it before it ...

A sustained reduction in deaths from prostate cancer was observed with prostate-specific antigen (PSA) testing in long-term follow-up results from the European Randomized Study of Screening for ...